Neurodevelopmental outcomes in women with PCOS and their children

  • Research type

    Research Study

  • Full title

    Autistic traits and the broad autism phenotype in women with polycystic ovary syndrome, and children of women with polycystic ovary syndrome

  • IRAS ID

    160585

  • Contact name

    Simon Baron-Cohen

  • Contact email

    sb205@cam.ac.uk

  • Sponsor organisation

    Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge

  • Research summary

    Previous research has indicated that elevated exposure to testosterone during a critical period of prenatal brain development increases the risk for autism spectrum conditions (ASC) and that levels of testosterone measured in amniotic fluid during this period are related to autistic traits. Furthermore, testosterone exposure during this period may also program the reproductive system in females, resulting in disruption of hormones, as seen in polycystic ovary syndrome (PCOS). The purpose of this study is to investigate the rate of autism, and the psychological profile related to autism, in women with polycystic ovary syndrome, and children born to women with polycystic ovary syndrome, as both groups may be exposed to higher levels of testosterone in utero. Participants will be asked to report any developmental diagnoses they or their biological children have received, and to take self- and parent-report questionnaires investigating the broad autism phenotype on a secure website. We believe that self-report of diagnoses will more accurately reflect the true prevalence in this population, as many women with autism seek a diagnosis privately because of the stigma associated with autism spectrum conditions.

  • REC name

    East of England - Cambridge Central Research Ethics Committee

  • REC reference

    14/EE/1119

  • Date of REC Opinion

    24 Sep 2014

  • REC opinion

    Unfavourable Opinion